MEDANTA — Global Health Balance Sheet
0.000.00%
- IN₹368.48bn
- IN₹364.11bn
- IN₹36.92bn
Annual balance sheet for Global Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,211 | 5,634 | 12,781 | 11,753 | 11,223 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,339 | 1,804 | 2,235 | 2,470 | 3,242 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,021 | 8,117 | 15,795 | 15,087 | 15,331 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 20,722 | 22,088 | 23,719 | 26,179 | 30,361 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 26,941 | 31,455 | 41,160 | 43,041 | 47,662 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,047 | 4,195 | 5,726 | 6,177 | 6,188 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 13,118 | 15,295 | 16,878 | 13,984 | 13,798 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 13,823 | 16,160 | 24,282 | 29,056 | 33,864 |
| Total Liabilities & Shareholders' Equity | 26,941 | 31,455 | 41,160 | 43,041 | 47,662 |
| Total Common Shares Outstanding |